Klinische Wochenschrift

, Volume 62, Issue 9, pp 417–422 | Cite as

Langzeitbeobachtung bei 15 Patienten mit differenziertem Schilddrüsenkarzinom und unklar erhöhten Plasmathyreoglobulinspiegeln (Tg)

  • H. -P. Stumpf
  • M. Hüfner
  • H. -J. Hermann
  • B. Kimmig
Originals

Long-term follow-up of 15 patients with differentiated thyroid cancer and elevated plasma thyroglobulin levels without evidence of recurrence

Summary

The follow-up of 15 patients with differentiated cancer of the thyroid was analysed retrospectively. All patients had persistent or developed elevated thyroglobulin (Tg) plasma levels (>10 ng/ml) after total thyroidectomy and 131 I therapy. There was no evidence of thyroid remnants or metastases in the 131 I whole body scan, bone scan, chest X-ray or clinical investigation. Nine of 15 patients developed local or distant metastases during a follow-up period of 3–39 months (mean=18 months). Only one of seven recurrences tested were 131 I positive, Tg values of 9 from 12 patients showed no correlation to the Thyroid-stimulating hormone (TSH) level. It is concluded that: (1) this group of patients is at high risk of developing a recurrence (2) new methods have to be developed for the localization of 131 I negative but Tg positive metastases.

Key words

Plasma thyroglobulin Thyroid cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ashcraft MW, Herle AJ van (1981) The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow up study of patients with treated differentiated thyroid cancer. Am J Med 71:806–814Google Scholar
  2. 2.
    Black EG, Gimlette TMD, Maisey MN, Cassoni A, Harmer CL, Oates GD (1981) Serum thyroglobulin in thyroid cancer. Lancet II:443Google Scholar
  3. 3.
    Black EG, Hoffenberg R (1982) Thyroglobulin and thyroid cancer. Lancet I:914Google Scholar
  4. 4.
    Botsch H, Schulz E, Lochner B (1979) Serum-thyreoglobulinbestimmung zur Verlaufskontrolle bei Schilddrüsenkarzinom-Patienten. Dtsch med Wochenschr 104:1072Google Scholar
  5. 5.
    Castagnoli A, Cappelli G, D'Agata A, Forni S, Milani S, Pupi A (1982) Can thyroglobulin assay really supplant radioiodine scans in patients with differentiated thyroid cancer? Lancet I:573Google Scholar
  6. 6.
    Charles MA, Dodson LE jr, Waldeck N, Hofeldt F, Ghaed N, Telepak R, Ownbey J, Burstein P (1980) Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma. Am J Med 69:401–407Google Scholar
  7. 7.
    Fairweather DS, Bradwell AR, Watson-James SF, Dykes PW, Hoffenberg R, Chandler S (1983) Detection of thyroid tumours using radio-labelled anti-thyroglobulin. Clin Endocrinol 18:563–570Google Scholar
  8. 8.
    Hüfner M, Pollmann H, Grussendorf M, Schenk P (1980) Die Bedeutung der Thyreoglobulinbestimmung im Serum bei der Nachsorge von Patienten mit differenziertem Schilddrüsenkarzinom. Schweiz Med Wochenschr 110:159–162Google Scholar
  9. 9.
    Hüfner M, Stumpf HP, Hermann HJ, Kimmig B (1983) Diagnostischer Wert des131J-Ganzkörperszintigramms in der Nachsorge des differenzierten Schilddrüsencarcinoms. Dtsch Med Wochenschr 108:1234Google Scholar
  10. 10.
    Jänsch A, Heinze HG, Hast B (1981) Serum-Thyreoglobulin (S-hTG): Ein Tumormarker bei Patienten mit differenziertem Schilddrüsenkarzinom. Strahlentherapie 157:381–392Google Scholar
  11. 11.
    Lo Gerfo P, Colacchio D, Stillman T, Feind D (1977) Serum thyroglobulin and recurrent thyroid cancer. Lancet I:881–882Google Scholar
  12. 12.
    Lo Gerfo P, Colacchio T, Colacchio D, Feind C (1979) Thyroglobulin in benign and malignant thyroid disease. J Am Med Assoc 241:923–925Google Scholar
  13. 13.
    Pinsky St, Bekermann C, Hoffer P (1978) Imaging Techniques in the Detection of Thyroid Cancer. In: Greenfield LD (ed) Thyroid Cancer. CRC Press Inc, p 59Google Scholar
  14. 14.
    Reiners Ch (1983) Serum-Thyreoglobulin und Thyreoglobulin-Antikörper. Thieme Copythek, Thieme, Stuttgart New York, pp 52–58Google Scholar
  15. 15.
    Shlossberg AH, Jacobson JC, Ibbertson HK (1979) Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin Endocrinol 10:17Google Scholar
  16. 16.
    Schlumberger M, Charbord P, Fragu P, Lumbroso J, Parmentier C, Tubiana M (1980) Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab 51:513–519Google Scholar
  17. 17.
    Schlumberger M, Fragu P, Parmentier C, Tubiana M (1981) Thyroglobulin assays in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue. Acta Endocrinol 98:215–221Google Scholar
  18. 18.
    Schneider AB, Line BR, Goldman JM, Robbins J (1981) Sequential serum thyroglobulin determinations,131I scans, and131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab 53:1199–1206Google Scholar
  19. 19.
    Stumpf HP, Hüfner M, Hermann HJ (1983) Long-term observation in 17 patients with treated differentiated thyroid cancer and isolated plasma thyroglobulin elevation. A retrospective study. Acta Endocrinol [Suppl] (Kbh) 102:253, 120Google Scholar
  20. 20.
    Van Herle AJ (1975) Elevated Serum Thyroglobulin: A Marker of Metastases in Differentiated Thyroid Carcinoma. J Clin Invest 56:272–277Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • H. -P. Stumpf
    • 1
  • M. Hüfner
    • 1
  • H. -J. Hermann
    • 2
  • B. Kimmig
    • 2
  1. 1.Medizinische Universitäts-PoliklinikGermany
  2. 2.Universitäts-Strahlenklinik HeidelbergGermany

Personalised recommendations